Is the housing market becoming a buyers' market - Bolton estate agent's view
Harrisons Estate Agents says 121,665 sales were agreed in May 2025, compared to 114,452 sales in May 2024, and 98,609 in the same month in 2023.
Estate agent, Clint Hibbert, said: "At first glance, that number stands out. More homes. More choice.
"But that's only half the story. Although the number of properties for sale locally has increased significantly since 2022, the number of homes selling has also increased."
More: Houses selling in just 35 days amid 'strong demand' across Bolton
More: Bolton home with 6 bedrooms and 2 reception rooms on market for £725k
More: More than 100 affordable homes coming to neighbouring town
Nationally, regionally, and locally in Bolton, activity is up, prices are fluid, and buyer behaviour is evolving, Mr Hibbert adds.
He explained: "This isn't just a market with more homes for sale; it's a market on the move. If you're buying, selling or just watching from the sidelines, the first half of 2025 has delivered some telling trends that every Bolton homeowner needs to understand."
What does it all mean for Bolton homeowners though?
Mr Hibbert added: "House prices are roughly stable; however, if you are selling, you face increased competition.
"Fifty-six per cent of properties that have left UK estate agents' books since January 1, 2025, have had their owners sell, exchange contracts, and move, with the remaining 44 per cent being withdrawn and unsold.
"This means that you only have a roughly one in two chance of selling if you put your home on the market. Therefore, accurate pricing is more critical than ever, but it isn't the only factor."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Google DeepMind has grand ambitions to ‘cure all diseases' with AI. Now, it's gearing up for its first human trials
Alphabet's Isomorphic Labs is preparing to launch human trials of AI-designed drugs, its president, Colin Murdoch, told Fortune. Born from DeepMind's AlphaFold breakthrough, the company is pairing cutting-edge AI with pharma veterans to design medicines faster, cheaper, and more accurately. Alphabet's secretive drug discovery arm, Isomorphic Labs, is getting ready to start testing its AI-designed drugs in humans, Colin Murdoch, Isomorphic Labs president and Google DeepMind's chief business officer, told Fortune. 'There are people sitting in our office in King's Cross, London, working, and collaborating with AI to design drugs for cancer,' Murdoch said during an interview in Paris. 'That's happening right now.' After years in development, Murdoch says human clinical trials for Isomorphic's AI-assisted drugs are finally in sight. 'The next big milestone is actually going out to clinical trials, starting to put these things into human beings,' he said. 'We're staffing up now. We're getting very close.' The company, which was spun out of DeepMind in 2021, was born from one of DeepMind's most celebrated breakthroughs, AlphaFold, an AI system capable of predicting protein structures with a high level of accuracy. Interactions of AlphaFold progressed from being able to accurately predict individual protein structures to modeling how proteins interact with other molecules like DNA and drugs. These leaps made it far more useful for drug discovery, helping researchers design medicines faster and more precisely, turning the tool into a launchpad for a much larger ambition. 'This was the inspiration for Isomorphic Labs,' Murdoch said of AlphaFold. 'It really demonstrates that we could do something very foundational in AI that could help unlock drug discovery.' In 2024, the same year it released AlphaFold 3, Isomorphic signed major research collaborations with pharma companies Novartis and Eli Lilly. A year later, in April 2025, Isomorphic Labs raised $600 million in its first-ever external funding round, led by Thrive Capital. The deals are part of Isomorphic's plan to build a 'world-class drug design engine,' a system that combines machine learning researchers with pharma veterans to design new medicines faster, more cheaply, and with a higher chance of success. As part of the deals with major pharma players, Isomorphic supports existing drug programs, but it also designs its own internal drug candidates in areas such as oncology and immunology, with the aim of eventually licensing them out after early-stage trials. 'We identify an unmet need, and we start our own drug design programs. We develop those, put them into human clinical trials… we haven't got that yet, but we're making good progress,' he said. Today, pharma companies often spend millions attempting to bring a single drug to market, sometimes with just a 10% chance of success once trials begin. Murdoch believes Isomorphic's tech could radically improve those odds. 'We're trying to do all these things: speed them up, reduce the cost, but also really improve the chance that we can be successful,' he says. He wants to harness AlphaFold's technology to get to a point where researchers have 100% conviction that the drugs they are developing are going to work in human trials. 'One day we hope to be able to say — well, here's a disease, and then click a button and out pops the design for a drug to address that disease,' Murdoch said. 'All powered by these amazing AI tools.' This story was originally featured on
Yahoo
an hour ago
- Yahoo
£10k to invest? Here's a hot dividend share that could deliver a £2,653 passive income over just 3 years
I'm not just interested in high near-term dividend yields when I'm buying stocks for passive income. I want dividend shares that can provide a sustainably large and growing dividend over time. As this table shows, Greencoat UK (LSE:UKW) is expected to deliver impressively on both counts during the next few years: Year Dividend per share (forecast) Dividend yield 2025 10.38p 8.6% 2026 10.70p 8.8% 2027 11.01p 9.1% It's critical to remember that dividends are never, ever guaranteed. What's more, City forecasts (upon which these yields are based) can shoot both under and above. Yet, I'm confident this dividend star an deliver a long-lasting second income for investors. If projections are accurate, a £10,000 lump sum today will provide dividends of £2,653 between now and 2027 alone. Here's why I'm considering the FTSE 250 company for my own portfolio. Holding renewable energy stocks can be problematic at times. When the sun doesn't shine or the wind doesn't blow, profits can tumble as energy generation slumps, potentially impacting dividends. This is a constant threat for Greencoat UK, all of whose assets are located in Britain, as its name implies. However, this tighter geographic footprint also has its advantages. Britain is famed for its excellent wind speeds and long coastlines, and offshore wind capacity often exceeds 50%, making it one of the world's leading places to build turbines. Capacity on future wind farms is tipped to rise as high as 65%, too, as technology improves. The UK is also becoming one of the most supportive environments in the world for green energy. Just last Friday (4 July), the government announced new plans to turbocharge the onshore wind industry through steps like simplifying the planning process and boosting supply chains. In doing so, the government is looking to almost double total onshore wind capacity, to 27GW-29GW by 2030. This provides significant scope for Greencoat UK, which currently owns 49 wind farms, to keep its progressive payout policy going. As you can see, annual dividends here have risen consistently since it listed on the London Stock Exchange more than a decade ago. The only exception came in 2024, when the company cut its long-term energy generation forecasts by 2.4%, leading to a drop in asset values. But with these changes made, City analysts are expecting dividends to start chugging higher again from 2025. The graphic also underlines another attractive feature of renewable energy stocks like this. Electricity demand remains generally stable during all economic conditions, even during high inflation and pandemic-related downturns. So while these companies can keep producing the energy, the revenues and cash flows continue to steadily roll in. While it's not without risks, I'm considering adding Greencoat UK to my own portfolio for a long-term income. The post £10k to invest? Here's a hot dividend share that could deliver a £2,653 passive income over just 3 years appeared first on The Motley Fool UK. More reading 5 Stocks For Trying To Build Wealth After 50 One Top Growth Stock from the Motley Fool Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has recommended Greencoat Uk Wind Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Motley Fool UK 2025 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
Labour policies ‘obscured' by rows over welfare and winter fuel
Labour policies are 'barely being noticed' and have been 'obscured' by rows over welfare and winter fuel, former leader Lord Neil Kinnock has said. Lord Kinnock – who led the party from 1983 to 1992 – told Sky News that a 'cloud hangs over the accomplishments of the Government', as Sir Keir Starmer marked a year in office this weekend. He said that the party have 'a series of really commendable and absolutely essential policies' and also suggested a wealth tax as a change that could 'commend' them to the general public. The week of Sir Keir's first anniversary in Number 10 saw the Prime Minister scrap a raft of the Government's proposed welfare reforms in the face of a backbench revolt. Asked what has gone wrong in Government, Lord Kinnock told the Sunday Morning With Trevor Phillips programme: 'What's gone wrong is really the lack of a narrative, a story of the objectives of the Government and where they're working towards it and how they're working towards it. 'They are working towards it with a series of really commendable and absolutely essential policies. 'They are barely noticed because they're obscured by all the song and dance and noise, drums banging and cymbals clashing of the winter fuel payment… the welfare programme, the two-child benefit cap, the cuts in development aid, all those negative things that really are heartily disliked across the Labour movement and more widely, much more widely.' He said that a 'cloud hangs over the accomplishments of the Government, which are substantial and will become greater, and people are not getting the message'. Lord Kinnock said there are things the party could do that 'would commend themselves to the great majority of the general public' and that these included 'asset taxes'. 'By going for an imposition of 2% on asset values above £10 million, say, which is a very big fortune, the Government would be in a position to collect £10 billion or £11 billion,' he said. Shadow chancellor Sir Mel Stride said he thought a wealth tax would be 'the worst thing to do' and opposed the idea of 'piling further taxes on the wealth creators'. He also told the same Sky News programme that it had been a 'year of utter underperformance' from Labour. 'Whether you look at illegal boats, migrants coming across the Channel, that's now at record levels, far from smashing the gangs, they're smashing all the records as to the numbers coming into our country. If you look at the chaotic U-turns that we've just had in the last few weeks,' he added. Analysis by the PA news agency found that Labour has seen a double-digit drop in support in the opinion polls since last year's general election. According to figures collated this week, the party has averaged 24% in polls in the past month, down 10 points from 34% in the weeks following the 2024 election. It is common for political parties to experience a slide in the polls after taking power – it has happened to every UK government bar one in the past 40 years – but a drop of this size is unusual. The last time it was in double digits was 1992/93, when the Tory administration led by former prime minister John Major saw its poll numbers fall 12 points, from an average of 43% in the weeks after the April 1992 election to 31% a year later. Liberal Democrat leader Sir Ed Davey accused the Prime Minister of 'almost sleep-walking to becoming continuity Rishi Sunak'. In an interview with the Guardian, Sir Ed pointed to the PM's record on welfare and European affairs among other things, and said: 'It's almost as if, like Sunak, a tweak here, a tweak there is all he thinks needs to be done.'
